|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$176,358,827 |
|
|
Indirect Value
|
$413,822,111 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$590,180,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
7
|
0
|
Stock
price went down : |
7
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
48.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-08 |
4 |
B |
$2.52 |
$76,860 |
I/I |
30,500 |
561,100 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2008-06-20 |
4 |
B |
$16.49 |
$98,693 |
I/I |
5,985 |
3,380,985 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2021-03-25 |
4 |
A |
$7.71 |
$99,999 |
I/I |
12,970 |
18,329,996 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2022-02-22 |
4 |
A |
$2.03 |
$100,000 |
I/I |
49,261 |
19,004,634 |
0 |
- |
|
PGEN |
Precigen Inc |
Director |
|
2023-03-09 |
4 |
A |
$1.17 |
$100,000 |
I/I |
85,470 |
31,337,786 |
0 |
- |
|
PGEN |
Precigen Inc |
|
|
2024-03-14 |
4 |
A |
$1.43 |
$100,000 |
I/I |
69,930 |
32,121,391 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2017-05-11 |
4 |
OE |
$10.37 |
$103,700 |
D/D |
10,000 |
3,562,388 |
0 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-25 |
4 |
B |
$13.48 |
$103,756 |
I/I |
7,697 |
543,652 |
2.25 |
- |
|
PGEN |
Precigen Inc |
|
|
2023-12-28 |
4 |
B |
$1.41 |
$136,327 |
I/I |
96,686 |
1,096,686 |
0.01 |
% |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2007-09-18 |
4 |
B |
$8.87 |
$137,387 |
I/I |
15,489 |
3,946,915 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-24 |
4 |
B |
$13.17 |
$140,827 |
I/I |
10,693 |
535,955 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2008-06-16 |
4 |
B |
$5.73 |
$147,834 |
I/I |
25,800 |
243,964 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-12-05 |
4 |
B |
$2.84 |
$151,940 |
I/I |
53,500 |
845,800 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-08-28 |
4 |
B |
$2.56 |
$153,600 |
I/I |
60,000 |
475,300 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
355,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2008-06-23 |
4 |
B |
$5.51 |
$157,845 |
I/I |
28,463 |
1,299,886 |
2.25 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-23 |
4 |
B |
$12.97 |
$162,125 |
I/I |
12,500 |
525,262 |
2.25 |
- |
|
PGEN |
Precigen Inc |
|
|
2023-08-16 |
4 |
B |
$1.51 |
$180,311 |
I/I |
119,411 |
31,837,786 |
0.01 |
% |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2006-09-13 |
4 |
B |
$2.50 |
$185,000 |
I/I |
74,000 |
658,300 |
1.5 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-08-29 |
4 |
B |
$15.00 |
$189,315 |
I/I |
12,621 |
570,263 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-01-31 |
4 |
A |
$7.66 |
$199,995 |
I/I |
26,109 |
16,083,751 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-03-29 |
4 |
A |
$5.26 |
$199,996 |
I/I |
38,022 |
16,146,867 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-02-28 |
4 |
A |
$7.97 |
$199,999 |
I/I |
25,094 |
16,108,845 |
0 |
- |
|
PGEN |
Precigen Inc |
Executive Chairman |
|
2020-03-31 |
4 |
A |
$2.61 |
$199,999 |
I/I |
76,628 |
10,588,601 |
0 |
- |
|
PGEN |
Precigen Inc |
Executive Chairman |
|
2020-01-31 |
4 |
A |
$6.02 |
$200,002 |
I/I |
33,223 |
18,528,842 |
0 |
- |
|
271 Records found
|
|
Page 4 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|